Shabana Abdullah Abdulqadir, NP

Shabana Abdulqadir practices at Mercy Medical Imaging in Merced, California.

Shabana Abdulqadir's NPI, 1184372047, was assigned on March 10, 2022. Shabana Abdulqadir holds California license 95020230.

Shabana Abdulqadir's primary practice is Mercy Medical Imaging, at 315 Mercy Ave. Ste. 102, Merced, CA 95340. The practice phone is (209) 564-3182.

Shabana Abdulqadir's primary practice is Mercy Medical Imaging in Merced, California. Shabana Abdulqadir is also affiliated with Dignity Health - Mercy Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Shabana Abdulqadir to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account. Shabana Abdulqadir's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Shabana Abdulqadir practices, 6 sites in all. Vendor and product names are available with a free account.

Family is Shabana Abdulqadir's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Shabana Abdulqadir is licensed in California.

Dmand AI lists acne, acute gastroduodenitis, acute skin infection, ankle or foot injury, anxiety, arthritis, asthma and bursitis among the conditions Shabana Abdulqadir treats.

CMS data shows 746 Medicare services from Shabana Abdulqadir across 12 procedure codes in 2024, for 234 Medicare patients. Medicare paid $55,445 for them. Every service was in an office.

CMS counts 234 Medicare patients who saw Shabana Abdulqadir in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Shabana Abdulqadir's median patient age at 66, with 76% women.

In 2024, Shabana Abdulqadir wrote 2,958 Medicare Part D claims for 256 patients. 84% of them were for generic drugs. CMS names the drug for 2,350 of them, across 68 drugs with 11 or more claims each, at $246,473 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Shabana Abdulqadir for performance year 2024, reported through an alternative payment model (APM). Shabana Abdulqadir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shabana Abdulqadir as offering telehealth.

CMS Open Payments shows 1 general payment to Shabana Abdulqadir from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $16.